je.st
news
Teva Agrees to Buy NuPathe for $144 Million, Outbidding Endo
2014-01-21 19:16:48| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd. agreed to buy NuPathe Inc. for $144 million, outbidding Endo Health Solutions Inc. to gain NuPathe's migraine patch.
Tags: buy
million
agrees
endo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|